Aura Biosciences Inc Investor Day Transcript
Good morning. My name is Chantal, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Aura Biosciences Virtual Investor Day. (Operator Instructions) As a reminder, today's call is being recorded.
I would now like to turn the call over to Elisabet de los Pinos, Chief Executive Officer of Aura Biosciences.
Yes. Thank you. Welcome to Aura Investor Day. We're excited. We have a very good agenda for the day. As you know, we are back from Chicago, where we had exciting data of our suprachoroidal administration with AU-011 Bel-Sar.
We have today the privilege to welcome 3 of the top key opinion leaders in the field of ocular oncology, and they will share with you their perspective, their opinion on our drug and in general, in the field of ocular oncology. And afterwards, we will have a moderated Q&A, and we look forward to all your questions.
So let me give you a brief overview of Aura. as you all know,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |